Landos Biopharma Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Landos Biopharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Landos Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Landos Biopharma is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors. ...more
Landos |
Landos Biopharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Landos Biopharma on October 28, 2025 and sell it today you would earn a total of 100.00 from holding Landos Biopharma or generate -100.0% return on investment over 90 days. Landos Biopharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Landos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Landos Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Landos Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Landos Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Landos Biopharma is not yet fully synchronised with the market data | |
| Landos Biopharma has some characteristics of a very speculative penny stock | |
| Landos Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (21.93 M) with profit before overhead, payroll, taxes, and interest of 18 M. | |
| Landos Biopharma currently holds about 55.75 M in cash with (20.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. |
Landos Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Landos Stock often depends not only on the future outlook of the current and potential Landos Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Landos Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.3 M | |
| Cash And Short Term Investments | 37.5 M |
Landos Biopharma Fundamentals Growth
Landos Stock prices reflect investors' perceptions of the future prospects and financial health of Landos Biopharma, and Landos Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Landos Stock performance.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.39 | |||
| Current Valuation | 42.67 M | |||
| Shares Outstanding | 3.13 M | |||
| Price To Book | 2.11 X | |||
| Price To Sales | 2.37 X | |||
| EBITDA | (22.73 M) | |||
| Cash And Equivalents | 55.75 M | |||
| Cash Per Share | 1.38 X | |||
| Total Debt | 27 K | |||
| Book Value Per Share | 7.43 X | |||
| Cash Flow From Operations | (20.48 M) | |||
| Earnings Per Share | (4.00) X | |||
| Total Asset | 38.04 M | |||
| Retained Earnings | (155.36 M) | |||
Things to note about Landos Biopharma performance evaluation
Checking the ongoing alerts about Landos Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Landos Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Landos Biopharma is not yet fully synchronised with the market data | |
| Landos Biopharma has some characteristics of a very speculative penny stock | |
| Landos Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (21.93 M) with profit before overhead, payroll, taxes, and interest of 18 M. | |
| Landos Biopharma currently holds about 55.75 M in cash with (20.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. |
- Analyzing Landos Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Landos Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining Landos Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Landos Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Landos Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Landos Biopharma's stock. These opinions can provide insight into Landos Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |